AT&T Demonstrates Asthma Sensor and 4 Hot Stocks Trading Now – Wall St. Cheat Sheet

AT&T Demonstrates Asthma Sensor and 4 Hot Stocks Trading Now
Wall St. Cheat Sheet
CVS Caremark Corporation (NYSE:CVS) sees its retail pharmacy SSS up 0.25 to 1.5 percent, and its pharmacy services segment net revenue growth was at 1.5 to 2.75 percent. The company claims that 2013?s profitability will be affected by various factors,

and more »

View full post on asthma – Google News

Verona Pharma announces positive results from mild asthma study – Trading Markets (press release)

Verona Pharma announces positive results from mild asthma study
Trading Markets (press release)
Verona Pharma plc, a biotechnology company, has completed a successful trial of higher doses of its lead respiratory drug, RPL554, in patients with mild asthma. The randomized, blinded trial, with placebo control, took place in Leiden, The Netherlands,

and more »

View full post on asthma – Google News

VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma – Trading Markets (press release)


Proactive Investors UK

VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma
Trading Markets (press release)
This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a
Verona Pharma starts Asthma drug trialProactive Investors UK
STOCKS NEWS UK-Verona gains positive update on key drugLondon South East
Verona Pharma up 20% on new drug trialStock Market Wire
Trading Markets (press release)
all 11 news articles »

View full post on asthma – Google News

Dr. Reddy’s Laboratories launches Zafirlukast tablets in US – Trading Markets (press release)

Dr. Reddy's Laboratories launches Zafirlukast tablets in US
Trading Markets (press release)
Laboratories (NYSE: RDY | PowerRating) reported on Saturday the launch of its Zafirlukast tablets (10mg and 20mg) in the US market, for treating asthma.
Dr Reddy's gets USFDA nodIndian Express
Dr. Reddy's launches generic AccolateDrug Store News
Dr Reddy's gets FDA nod to launch Zafirlukast in USSify
Indlaw.com
all 57 news articles »

View full post on asthma – Google News

KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … – Trading Markets (press release)

KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy
Trading Markets (press release)
Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates,
Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI MeetingBiomed Middle East

all 19 news articles »

View full post on asthma – Google News